Author:
Moriceau Guillaume,Vallard Alexis,Rivoirard Romain,Méry Benoîte,Espenel Sophie,Langrand-Escure Julien,Ben Mrad Majed,Wang Guoping,Diao Peng,Pacaut Cécile,Guillot Aline,Collard Olivier,Fournel Pierre,Magné Nicolas
Reference17 articles.
1. Analyse économique des couts du cancer en France;Amalric,2007
2. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium;Sternberg;J Urol,1988
3. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000
4. Second-line treatment of advanced transitional cell carcinoma of the urothelial tract;Sternberg;Curr Opin Urol,2001
5. Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy;Sternberg;Cancer,2001
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献